Published in Microb Cell Fact on February 07, 2013
Recombinant polypeptide production in E. coli: towards a rational approach to improve the yields of functional proteins. Microb Cell Fact (2013) 0.83
Influence of pH control in the formation of inclusion bodies during production of recombinant sphingomyelinase-D in Escherichia coli. Microb Cell Fact (2014) 0.79
Glutaraldehyde: behavior in aqueous solution, reaction with proteins, and application to enzyme crosslinking. Biotechniques (2004) 2.79
Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact (2005) 1.79
Carbohydrates as future anti-adhesion drugs for infectious diseases. Biochim Biophys Acta (2006) 1.75
SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog (2006) 1.68
General principles of antimicrobial therapy. Mayo Clin Proc (2011) 1.42
Meaning and therapeutic potential of microbial recognition of host glycoconjugates. Mol Microbiol (1998) 1.42
Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract. Gut (2011) 1.39
Molecular dimensions of Hb-based O(2) carriers determine constriction of resistance arteries and hypertension. Am J Physiol Heart Circ Physiol (2000) 1.37
High activity of inclusion bodies formed in Escherichia coli overproducing Clostridium thermocellum endoglucanase D. FEBS Lett (1991) 1.35
A self-cleavable sortase fusion for one-step purification of free recombinant proteins. Protein Expr Purif (2004) 1.18
The formation of biologically active beta-galactosidase inclusion bodies in Escherichia coli. Aust J Biotechnol (1989) 1.17
Isolation of biologically active nanomaterial (inclusion bodies) from bacterial cells. Microb Cell Fact (2010) 1.10
Bacterial inclusion bodies: making gold from waste. Trends Biotechnol (2011) 1.07
Fusion to a pull-down domain: a novel approach of producing Trigonopsis variabilisD-amino acid oxidase as insoluble enzyme aggregates. Biotechnol Bioeng (2007) 1.06
Pathogenesis of Helicobacter pylori infection. Helicobacter (2011) 1.05
Nanomicellar formulations for sustained drug delivery: strategies and underlying principles. Nanomedicine (Lond) (2010) 1.04
Carbohydrate engineered cells for regenerative medicine. Adv Drug Deliv Rev (2010) 1.04
A crosslinked inclusion body process for sialic acid synthesis. J Biotechnol (2008) 1.02
Enzymatic synthesis of sialylation substrates powered by a novel polyphosphate kinase (PPK3). Org Biomol Chem (2009) 0.94
Targeting lectin activity into inclusion bodies for the characterisation of glycoproteins. Mol Biosyst (2009) 0.94
The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation. Biomaterials (2010) 0.90
Glyco-nanomaterials: translating insights from the "sugar-code" to biomedical applications. Curr Med Chem (2011) 0.90
Streamlined protein expression and purification using cleavable self-aggregating tags. Microb Cell Fact (2011) 0.90
Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies. Adv Mater (2012) 0.89
Quantitative modeling assesses the contribution of bond strengthening, rebinding and force sharing to the avidity of biomolecule interactions. PLoS One (2012) 0.87
Packaging protein drugs as bacterial inclusion bodies for therapeutic applications. Microb Cell Fact (2012) 0.86
On the mechanism of stomatocyte-echinocyte transformations of red blood cells: experiment and theoretical model. Colloids Surf B Biointerfaces (2004) 0.84
Inclusion bodies as potential vehicles for recombinant protein delivery into epithelial cells. Microb Cell Fact (2012) 0.83
Size characterization of inclusion bodies by sedimentation field-flow fractionation. J Biotechnol (2008) 0.83
Biotinylated-sortase self-cleavage purification (BISOP) method for cell-free produced proteins. BMC Biotechnol (2010) 0.81
Purification of green fluorescent protein using a two-intein system. Appl Microbiol Biotechnol (2007) 0.80
Light-mimicking cockroaches indicate Tertiary origin of recent terrestrial luminescence. Naturwissenschaften (2012) 2.05
Polyphosphate--an ancient energy source and active metabolic regulator. Microb Cell Fact (2011) 1.19
A crosslinked inclusion body process for sialic acid synthesis. J Biotechnol (2008) 1.02
Lectinomics II. A highway to biomedical/clinical diagnostics. Biotechnol Adv (2008) 1.02
Carrier-free immobilized enzymes for biocatalysis. Biotechnol Lett (2009) 0.95
Properties of hydrogel materials used for entrapment of microbial cells in production of fermented beverages. Artif Cells Blood Substit Immobil Biotechnol (2002) 0.84
Survival of human islets in microbeads containing high guluronic acid alginate crosslinked with Ca2+ and Ba2+. Xenotransplantation (2012) 0.82
Luminescent system of Lucihormetica luckae supported by fluorescence lifetime imaging. Naturwissenschaften (2013) 0.80
Free-radical degradation of high-molecular-weight hyaluronan induced by ascorbate plus cupric ions. Testing of bucillamine and its SA981-metabolite as antioxidants. J Pharm Biomed Anal (2011) 0.77
Degradation of high-molar-mass hyaluronan by ascorbate plus cupric ions: effects of D-penicillamine addition. Chem Biodivers (2009) 0.76
Insoluble protein applications: the use of bacterial inclusion bodies as biocatalysts. Methods Mol Biol (2015) 0.76
The impact of growth conditions on biofilm formation and the cell surface hydrophobicity in fluconazole susceptible and tolerant Candida albicans. Folia Microbiol (Praha) (2014) 0.76
Degradation of polyphosphates by polyphosphate kinases from Ruegeria pomeroyi. Biotechnol Lett (2014) 0.76
Quantitative analysis of energy transfer between fluorescent proteins in CFP-GBP-YFP and its response to Ca2+. Phys Chem Chem Phys (2011) 0.76
The degradative action of peroxynitrite on high-molecular-weight hyaluronan. Neuro Endocrinol Lett (2006) 0.75
Aurothiomalate as preventive and chain-breaking antioxidant in radical degradation of high-molar-mass hyaluronan. Chem Biodivers (2011) 0.75
Physical and bioengineering properties of polyvinyl alcohol lens-shaped particles versus spherical polyelectrolyte complex microcapsules as immobilisation matrices for a whole-cell Baeyer-Villiger monooxygenase. Appl Biochem Biotechnol (2014) 0.75
Viability of free and encapsulated Escherichia coli overexpressing cyclopentanone monooxygenase monitored during model Baeyer-Villiger biooxidation by confocal laser scanning microscopy. Biotechnol Lett (2011) 0.75
Flow calorimetry--a useful tool for determination of immobilized cis-epoxysuccinate hydrolase activity from Nocardia tartaricans. Artif Cells Blood Substit Immobil Biotechnol (2004) 0.75